Canada - English - Health Canada

accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

Canada - English - Health Canada

accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

Canada - English - Health Canada

apotex inc - methotrexate (methotrexate sodium) - tablet - 2.5mg - methotrexate (methotrexate sodium) 2.5mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

mylan institutional llc - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 25 mg/ml (as methotrexate sodium) - solution for injection - 7.5 mg/0.3ml - active: methotrexate 25 mg/ml (as methotrexate sodium) excipient: sodium chloride sodium hydroxide water for injection - methotrexate may be of value in the symptomatic control of server, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - methotrexate sodium - oral solution - 2mg/1ml

Singapore - English - HSA (Health Sciences Authority)

accord healthcare private limited - methotrexate disodium eqv to methotrexate - tablet - methotrexate disodium eqv to methotrexate 2.5 mg

Canada - English - Health Canada

lederle cyanamid canada inc. - methotrexate (methotrexate sodium) - liquid - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

Canada - English - Health Canada

lederle cyanamid canada inc. - methotrexate (methotrexate sodium) - powder for solution - 20mg - methotrexate (methotrexate sodium) 20mg - antineoplastic agents

Canada - English - Health Canada

david bull laboratories (pty) ltd. - methotrexate (methotrexate sodium) - liquid - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents